The lncRNA LAMP5-AS1 drives leukemia cell stemness by directly modulating DOT1L methyltransferase activity in MLL leukemia
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-8722
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
The lncRNA LAMP5-AS1 drives leukemia cell stemness by directly modulating DOT1L methyltransferase activity in MLL leukemia ; volume:13 ; number:1 ; day:17 ; month:6 ; year:2020 ; pages:1-19 ; date:12.2020
Journal of hematology & oncology ; 13, Heft 1 (17.6.2020), 1-19, 12.2020
- Urheber
-
Wang, Wen-Tao
Chen, Tian-Qi
Zeng, Zhan-Cheng
Pan, Qi
Huang, Wei
Han, Cai
Fang, Ke
Sun, Lin-Yu
Yang, Qian-Qian
Wang, Dan
Luo, Xue-Qun
Sun, Yu-Meng
Chen, Yue-Qin
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13045-020-00909-y
- URN
-
urn:nbn:de:101:1-2020081411465995130585
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:54 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Wang, Wen-Tao
- Chen, Tian-Qi
- Zeng, Zhan-Cheng
- Pan, Qi
- Huang, Wei
- Han, Cai
- Fang, Ke
- Sun, Lin-Yu
- Yang, Qian-Qian
- Wang, Dan
- Luo, Xue-Qun
- Sun, Yu-Meng
- Chen, Yue-Qin
- SpringerLink (Online service)
Ähnliche Objekte (12)
Correction to: The lncRNA LAMP5-AS1 drives leukemia cell stemness by directly modulating DOT1L methyltransferase activity in MLL leukemia
MLL-r Leukemia
MLL oncoprotein levels influence leukemia lineage identities
RNA binding proteins in MLL-rearranged leukemia
How to effectively treat acute leukemia patients bearing MLL-rearrangements ?
MLL-fusion-driven leukemia requires SETD2 to safeguard genomic integrity
Pharmacological inhibition of LSD1 for the treatment of MLL-rearranged leukemia
SUV39H1 regulates the progression of MLL-AF9-induced acute myeloid leukemia
Thiopurine methyltransferase polymorphisms in children with acute lymphoblastic leukemia
FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia
Functional diversity of inhibitors tackling the differentiation blockage of MLL-rearranged leukemia
Thiopurine methyltransferase genotyping in Palestinian childhood acute lymphoblastic leukemia patients
Correction to: The lncRNA LAMP5-AS1 drives leukemia cell stemness by directly modulating DOT1L methyltransferase activity in MLL leukemia
MLL-r Leukemia
MLL oncoprotein levels influence leukemia lineage identities
RNA binding proteins in MLL-rearranged leukemia
How to effectively treat acute leukemia patients bearing MLL-rearrangements ?
MLL-fusion-driven leukemia requires SETD2 to safeguard genomic integrity
Pharmacological inhibition of LSD1 for the treatment of MLL-rearranged leukemia
SUV39H1 regulates the progression of MLL-AF9-induced acute myeloid leukemia
Thiopurine methyltransferase polymorphisms in children with acute lymphoblastic leukemia
FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia
Functional diversity of inhibitors tackling the differentiation blockage of MLL-rearranged leukemia
Thiopurine methyltransferase genotyping in Palestinian childhood acute lymphoblastic leukemia patients
Correction to: The lncRNA LAMP5-AS1 drives leukemia cell stemness by directly modulating DOT1L methyltransferase activity in MLL leukemia
MLL-r Leukemia
MLL oncoprotein levels influence leukemia lineage identities
RNA binding proteins in MLL-rearranged leukemia
How to effectively treat acute leukemia patients bearing MLL-rearrangements ?
MLL-fusion-driven leukemia requires SETD2 to safeguard genomic integrity
Pharmacological inhibition of LSD1 for the treatment of MLL-rearranged leukemia
SUV39H1 regulates the progression of MLL-AF9-induced acute myeloid leukemia
Thiopurine methyltransferase polymorphisms in children with acute lymphoblastic leukemia
FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia
Functional diversity of inhibitors tackling the differentiation blockage of MLL-rearranged leukemia